Myelodysplastic syndromes: An analysis of non-hematological prognostic factors and its relationship to age

Ana Patrícia Nogueira Aguiar; Priscila da Silva Mendonça; Howard Lopes Ribeiro-Júnior; Daniela de Paula Borges; Helena Alves de Carvalho Sampaio; Manoel Ricardo Alves Martins; Ronald Feitosa Pinheiro; Silvia Maria Meira Magalhães

doi:10.1016/j.jgo.2019.06.021

Myelodysplastic syndromes: An analysis of non-hematological prognostic factors and its relationship to age

J Geriatr Oncol. 2020 Jan;11(1):125-127. doi: 10.1016/j.jgo.2019.06.021. Epub 2019 Jul 11.

Authors

Ana Patrícia Nogueira Aguiar¹, Priscila da Silva Mendonça², Howard Lopes Ribeiro-Júnior³, Daniela de Paula Borges⁴, Helena Alves de Carvalho Sampaio⁵, Manoel Ricardo Alves Martins⁶, Ronald Feitosa Pinheiro⁷, Silvia Maria Meira Magalhães⁸

Affiliations

¹ Cancer Cytogenomic Laboratory, Federal University of Ceará, Fortaleza, Brazil; Post-graduate Program in Medical Science, Federal University of Ceará, Fortaleza, Brazil; Center for Research and Drug Development (NPDM), Federal University of Ceará, Fortaleza, Ceara, Brazil. Electronic address: patricianogueiraaguiar@yahoo.com.br.
² Cancer Cytogenomic Laboratory, Federal University of Ceará, Fortaleza, Brazil; Post-graduate Program in Medical Science, Federal University of Ceará, Fortaleza, Brazil; University Hospital Walter Cantidio, Brazilian Company of Hospital Services, Fortaleza, Ceará, Brazil.; Center for Research and Drug Development (NPDM), Federal University of Ceará, Fortaleza, Ceara, Brazil.
³ Cancer Cytogenomic Laboratory, Federal University of Ceará, Fortaleza, Brazil; Center for Research and Drug Development (NPDM), Federal University of Ceará, Fortaleza, Ceara, Brazil.
⁴ Cancer Cytogenomic Laboratory, Federal University of Ceará, Fortaleza, Brazil; Post-graduate Program in Medical Science, Federal University of Ceará, Fortaleza, Brazil; Center for Research and Drug Development (NPDM), Federal University of Ceará, Fortaleza, Ceara, Brazil.
⁵ Post-graduate Program in Public Health, State University of Ceará, Fortaleza, Brazil.
⁶ Department of Clinical Medicine, Federal University of Ceará, Fortaleza, Brazil; Post-Graduate Program of Pathology, Federal University of Ceará, Fortaleza, Ceara, Brazil.; Center for Research and Drug Development (NPDM), Federal University of Ceará, Fortaleza, Ceara, Brazil.
⁷ Cancer Cytogenomic Laboratory, Federal University of Ceará, Fortaleza, Brazil; Post-graduate Program in Medical Science, Federal University of Ceará, Fortaleza, Brazil; Department of Clinical Medicine, Federal University of Ceará, Fortaleza, Brazil; Post-Graduate Program of Pathology, Federal University of Ceará, Fortaleza, Ceara, Brazil.; Center for Research and Drug Development (NPDM), Federal University of Ceará, Fortaleza, Ceara, Brazil.
⁸ Cancer Cytogenomic Laboratory, Federal University of Ceará, Fortaleza, Brazil; Post-graduate Program in Medical Science, Federal University of Ceará, Fortaleza, Brazil; Department of Clinical Medicine, Federal University of Ceará, Fortaleza, Brazil; Center for Research and Drug Development (NPDM), Federal University of Ceará, Fortaleza, Ceara, Brazil.

PMID: 31303462
DOI: 10.1016/j.jgo.2019.06.021

No abstract available

Keywords: Comorbidity; Frailty; Metabolic syndrome; Myelodysplastic syndrome; Nutritional status; Polypharmacy.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Comorbidity
Geriatric Assessment
Humans
Myelodysplastic Syndromes* / diagnosis
Myelodysplastic Syndromes* / epidemiology
Prognosis